BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
出版年份 2021 全文链接
标题
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
作者
关键词
-
出版物
NATURE MEDICINE
Volume 27, Issue 12, Pages 2136-2143
出版商
Springer Science and Business Media LLC
发表日期
2021-11-02
DOI
10.1038/s41591-021-01583-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
- (2021) Laith J. Abu-Raddad et al. Scientific Reports
- SARS-CoV-2 infection is at herd immunity in the majority segment of the population of Qatar
- (2021) Mohamed H Al-Thani et al. Open Forum Infectious Diseases
- Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
- (2021) Mohammad R. Hasan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar
- (2021) Roberto Bertollini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses
- (2021) Laith J Abu-Raddad et al. JOURNAL OF TRAVEL MEDICINE
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
- (2021) Aziz Sheikh et al. LANCET
- mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
- (2021) Hiam Chemaitelly et al. NATURE MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar
- (2021) Jayaprakash Saththasivam et al. SCIENCE OF THE TOTAL ENVIRONMENT
- SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
- (2021) Shaheen Seedat et al. Scientific Reports
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
- (2021) Srinivas Nanduri et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
- (2021) Ashley Fowlkes et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
- (2021) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021
- (2021) Kristina L. Bajema et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021
- (2021) Shaun J. Grannis et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
- (2021) Peter V. Coyle et al. iScience
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- (2021) Sara Y Tartof et al. LANCET
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls
- (2017) Jennifer R. Verani et al. VACCINE
- Analysis of matched case-control studies
- (2016) Neil Pearce BMJ-British Medical Journal
- Analysis of matched case-control studies
- (2016) Neil Pearce BMJ-British Medical Journal
- The test-negative design for estimating influenza vaccine effectiveness
- (2013) Michael L. Jackson et al. VACCINE
- Is it necessary to adjust for calendar time in a test negative design?
- (2013) Peter Jacoby et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now